177 related articles for article (PubMed ID: 23303576)
1. Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control.
Kuuranne T; Ahola L; Pussinen C; Leinonen A
Drug Test Anal; 2013 Aug; 5(8):614-8. PubMed ID: 23303576
[TBL] [Abstract][Full Text] [Related]
2. Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use.
Butch AW; Ahrens BD; Avliyakulov NK
Drug Test Anal; 2018 Jun; 10(6):956-960. PubMed ID: 29098788
[TBL] [Abstract][Full Text] [Related]
3. Analysis of luteinizing hormone (LH): Validation of a commercial ELISA kit for LH analysis and quantification in doping control samples.
Mäkelä R; Leinonen A; Suominen T
Drug Test Anal; 2020 Feb; 12(2):239-246. PubMed ID: 31655497
[TBL] [Abstract][Full Text] [Related]
4. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
Butch AW; Woldemariam GA
Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
[TBL] [Abstract][Full Text] [Related]
5. "Application of the ultra micro analytical system (SUMA) technology for the detection of urinary hCG in antidoping control".
Martinez Brito D; Bueno Fis E; Fiallo Fernandez T; Torres Castellanos M; Correa Vidal MT; Montes De Oca Porto R
J Immunoassay Immunochem; 2018; 39(6):672-686. PubMed ID: 30346873
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
Robinson N; Sottas PE; Saugy M
Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
[TBL] [Abstract][Full Text] [Related]
7. Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis.
Lund H; Snilsberg AH; Halvorsen TG; Hemmersbach P; Reubsaet L
Bioanalysis; 2013 Mar; 5(5):623-30. PubMed ID: 23425277
[TBL] [Abstract][Full Text] [Related]
8. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
9. Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine.
Woldemariam GA; Butch AW
Clin Chem; 2014 Aug; 60(8):1089-97. PubMed ID: 24899693
[TBL] [Abstract][Full Text] [Related]
10. Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control.
Stenman UH; Unkila-Kallio L; Korhonen J; Alfthan H
Clin Chem; 1997 Jul; 43(7):1293-8. PubMed ID: 9216477
[TBL] [Abstract][Full Text] [Related]
11. Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control.
Shahzad K; Kim DH; Kang MJ
Clin Biochem; 2007 Nov; 40(16-17):1259-65. PubMed ID: 17884034
[TBL] [Abstract][Full Text] [Related]
12. Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations.
Strahm E; Marques-Vidal P; Pralong F; Dvorak J; Saugy M; Baume N
Forensic Sci Int; 2011 Dec; 213(1-3):62-72. PubMed ID: 21798680
[TBL] [Abstract][Full Text] [Related]
13. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples.
Birken S; Chen Y; Gawinowicz MA; Lustbader JW; Pollak S; Agosto G; Buck R; O'Connor J
Endocrinology; 1993 Sep; 133(3):1390-7. PubMed ID: 7689955
[TBL] [Abstract][Full Text] [Related]
14. Doping control of testosterone and human chorionic gonadotrophin: a case study.
de Boer D; de Jong EG; van Rossum JM; Maes RA
Int J Sports Med; 1991 Feb; 12(1):46-51. PubMed ID: 2030059
[TBL] [Abstract][Full Text] [Related]
15. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
[TBL] [Abstract][Full Text] [Related]
16. Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males.
Lund H; Snilsberg AH; Paus E; Halvorsen TG; Hemmersbach P; Reubsaet L
Anal Bioanal Chem; 2013 Feb; 405(5):1569-76. PubMed ID: 23203507
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.
Cole LA; Kardana A; Andrade-Gordon P; Gawinowicz MA; Morris JC; Bergert ER; O'Connor J; Birken S
Endocrinology; 1991 Sep; 129(3):1559-67. PubMed ID: 1714836
[TBL] [Abstract][Full Text] [Related]
18. Estimating the hCGβcf in urine during pregnancy.
Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
[TBL] [Abstract][Full Text] [Related]
19. Specificity and detection limit of ten pregnancy tests.
Alfthan H; Björses UM; Tiitinen A; Stenman UH
Scand J Clin Lab Invest Suppl; 1993; 216():105-13. PubMed ID: 7690982
[TBL] [Abstract][Full Text] [Related]
20. The biological and clinical significance of nicks in human chorionic gonadotropin and its free beta-subunit.
Cole LA; Kardana A; Ying FC; Birken S
Yale J Biol Med; 1991; 64(6):627-37. PubMed ID: 1725683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]